OncoSignal

Salah-Eddin Al-Batran

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · Frankfurter Insitut für Klinische Krebsforschung IKF · Institut für Klinische Krebsforschung IKF GmbH

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
47
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
117
PubMed author-name match

Trials

Studies that name Salah-Eddin Al-Batran as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:59 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:59 UTC. The ranking covers the 200 most relevant of 117 PubMed records, and a shared surname and initials can bring in a namesake. All 117 on PubMed

  1. 2,188 citations
    RCR 101.7
  2. 1,448 citations
    RCR 43.0
  3. 810 citations
    RCR 32.3
  4. 768 citations
    RCR 20.2
  5. 645 citations
    RCR 15.9
  6. 601 citations
    RCR 22.0
  7. 405 citations
    RCR 12.9
  8. 399 citations
    RCR 11.2
  9. 393 citations
    RCR 15.9
  10. 363 citations
    RCR 7.8